FDA approved Pylarify TruVu, a higher-radioactivity-concentration formulation of piflufolastat F 18 designed to increase batch size and distribution efficiency while maintaining the established ...

Metastatic prostate cancer is currently associated with high morbidity and mortality rates. In addition, patients respond very differently to standard treatments such as hormone therapy or radiation ...

The patient and local surgical team were located in Gibraltar, about 2,400 kilometers (about 1,500 miles) away. The procedure ...

In oligometastatic castration-resistant prostate cancer, the rationale to use local SBRT is improved disease control.

A large national study in Denmark following nearly 1,900 patients over almost a decade has found that a minimally invasive ...